Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:16 PM
Ignite Modification Date:
2025-12-24 @ 2:16 PM
NCT ID:
NCT01986595
Eligibility Criteria:
Inclusion Criteria:
1. Diagnosed by clinical criteria(one of below)
Proved or maybe as Neuroblastoma by :
1. pathological section
2. Bone meta with 24 hrs urine Vanillylmandelic acid(VMA)or Homovanillic acid(HVA) elevated
3. CT or MRI found tumor around adrenal gland or Neuroblastic tumor
2. Have tumor or blood samples to analyze ALK gene：
1. will operation to remove tumor or biopsy, and will preserve tumor sample；or
2. after operation and have tumor sample preserved；or
3. after operation without tumor sample, but agree to take blood sample to analyze ALK mutation
3. Signed Inform Consent Form
Exclusion Criteria:
(1) After informed but still not consent
Healthy Volunteers:
True
Sex:
ALL
Maximum Age:
50 Years
Study:
NCT01986595
Study Brief:
Protocol Section:
NCT01986595